BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12413646)

  • 21. Cannabis--psychosis pathway independent of other types of psychopathology.
    Ferdinand RF; van der Ende J; Bongers I; Selten JP; Huizink A; Verhulst FC
    Schizophr Res; 2005 Nov; 79(2-3):289-95. PubMed ID: 16125368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults.
    McGrath J; Welham J; Scott J; Varghese D; Degenhardt L; Hayatbakhsh MR; Alati R; Williams GM; Bor W; Najman JM
    Arch Gen Psychiatry; 2010 May; 67(5):440-7. PubMed ID: 20194820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of comorbid cannabis use on outcome in first episode psychosis.
    Hadden KL; LeDrew K; Hogan K; Thomas B
    Early Interv Psychiatry; 2018 Oct; 12(5):848-855. PubMed ID: 27592556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis consumption and psychosis or schizophrenia development.
    Ortiz-Medina MB; Perea M; Torales J; Ventriglio A; Vitrani G; Aguilar L; Roncero C
    Int J Soc Psychiatry; 2018 Nov; 64(7):690-704. PubMed ID: 30442059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis risk.
    Konings M; Stefanis N; Kuepper R; de Graaf R; ten Have M; van Os J; Bakoula C; Henquet C
    Psychol Med; 2012 Jan; 42(1):149-59. PubMed ID: 21676285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
    González-Ortega I; Alberich S; Echeburúa E; Aizpuru F; Millán E; Vieta E; Matute C; González-Pinto A
    PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence.
    Harley M; Kelleher I; Clarke M; Lynch F; Arseneault L; Connor D; Fitzpatrick C; Cannon M
    Psychol Med; 2010 Oct; 40(10):1627-34. PubMed ID: 19995476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of cannabis use expectancies on cannabis use and psychotic symptoms in psychosis.
    Hides L; Kavanagh DJ; Dawe S; Young RM
    Drug Alcohol Rev; 2009 May; 28(3):250-6. PubMed ID: 18608451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxiety mediates the association between cannabis use and attenuated positive psychotic symptoms.
    Reeves LE; Anglin DM; Heimberg RG; Gibson LE; Fineberg AM; Maxwell SD; Kerns CM; Ellman LM
    Psychiatry Res; 2014 Aug; 218(1-2):180-6. PubMed ID: 24745470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample.
    Auther AM; Cadenhead KS; Carrión RE; Addington J; Bearden CE; Cannon TD; McGlashan TH; Perkins DO; Seidman L; Tsuang M; Walker EF; Woods SW; Cornblatt BA
    Acta Psychiatr Scand; 2015 Jul; 132(1):60-8. PubMed ID: 25572323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis.
    Dragt S; Nieman DH; Schultze-Lutter F; van der Meer F; Becker H; de Haan L; Dingemans PM; Birchwood M; Patterson P; Salokangas RK; Heinimaa M; Heinz A; Juckel G; Graf von Reventlow H; French P; Stevens H; Ruhrmann S; Klosterkötter J; Linszen DH;
    Acta Psychiatr Scand; 2012 Jan; 125(1):45-53. PubMed ID: 21883099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood abuse in the etiological continuum underlying psychosis from first-episode psychosis to psychotic experiences.
    Alemany S; Ayesa-Arriola R; Arias B; Fatjó-Vilas M; Ibáñez MI; Ortet G; Crespo-Facorro B; Fañanás L
    Eur Psychiatry; 2015 Jan; 30(1):38-42. PubMed ID: 25284334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis and psychosis: what is the link?
    Ben Amar M; Potvin S
    J Psychoactive Drugs; 2007 Jun; 39(2):131-42. PubMed ID: 17703707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis use and subclinical positive psychotic experiences in early adolescence: findings from a Dutch survey.
    van Gastel WA; Wigman JT; Monshouwer K; Kahn RS; van Os J; Boks MP; Vollebergh WA
    Addiction; 2012 Feb; 107(2):381-7. PubMed ID: 21851445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad.
    Konings M; Henquet C; Maharajh HD; Hutchinson G; Van Os J
    Acta Psychiatr Scand; 2008 Sep; 118(3):209-13. PubMed ID: 18452569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.
    Thornton LK; Baker AL; Johnson MP; Lewin T
    Addict Behav; 2013 Jun; 38(6):2246-51. PubMed ID: 23507458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting the association between childhood trauma and psychosis in bipolar disorder: A quasi-dimensional path-analysis.
    Etain B; Lajnef M; Bellivier F; Henry C; M'bailara K; Kahn JP; Leboyer M; Fisher HL
    J Psychiatr Res; 2017 Jan; 84():73-79. PubMed ID: 27705819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.